FUNDING CANCER - Revision Applications for Validation of Biomarker Assays Developed through NIH-Supported Research Grants
Sponsor: NIH
Description: Through this NOFO, the National Cancer Institute encourages revision applications from currently funded NCI R01 research projects. The applicants should propose projects that are expected to accelerate the pace of translation of NCI-supported methods/assays/technologies to the clinic. Specifically, applications should focus on the adaptation of clinical validation of molecular/cellular/imaging markers for cancer detection, diagnosis, prognosis, monitoring, and prediction of response in treatment.
- Applications Due:
- February 14, 2025
- July 11, 2025
- October 15, 2025
- February 13, 2025
- July 10, 2026
- October 14, 2026
To view all current UVACCC funding opportunities, please click here.
For all open cancer-related funding opportunities, please click here.
There are no files to display.
